DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE SODIUM SUCCINATE

All Clinical Trials for Methylprednisolone Sodium Succinate

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000579	Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1994-09-01	The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.
NCT00290602	Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome	Completed	National Cancer Center, Korea	Phase 2	2004-02-01	The purpose of this study is to determine whether the 2mg/kg administration of corticosteroids, in the form of methylprednisolone sodium succinate, in early phase acute respiratory distress syndrome after thoracic surgery, will reduce the postoperative mortality.
NCT00295269	Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1997-03-01	The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.
NCT01046786	Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord	Completed	Chinese University of Hong Kong	Phase 1/Phase 2	2010-01-01	To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
NCT01046786	Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord	Completed	The University of Hong Kong	Phase 1/Phase 2	2010-01-01	To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
NCT01046786	Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord	Completed	China Spinal Cord Injury Network	Phase 1/Phase 2	2010-01-01	To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
NCT01354483	Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury	Completed	Chengdu PLA General Hospital	Phase 1/Phase 2	2011-09-01	The purpose of this study is to investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary